CBU
GOSS icon

CIBC Bancorp USA’s Gossamer Bio GOSS Stock Holding History

CIBC Bancorp USA’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$53.2K Buy
+20,246
New +$44.6K ﹤0.01% 1410

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CIBC Bancorp USA's GOSS Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in Gossamer Bio (GOSS) in Q3 2025: 20,246 shares worth $53.2K. The stake represents ﹤0.01% of the portfolio and ranks #1410 among its holdings.

164 funds tracked by Wall St. Rank hold GOSS as of Q3 2025.

  • CIBC Bancorp USA held 20,246 shares of Gossamer Bio worth $53.2K as of Q3 2025.
  • Gossamer Bio was a new CIBC Bancorp USA position in Q3 2025.
  • Gossamer Bio made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1410 holding.
  • 164 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.